Evaluation of the matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves
Source abstract
Abstract
Our goal is to fabricate continuous sheets of elastin atop non-biodegradable hydrogels (hylans) containing crosslinked hyaluronan, a glycosaminoglycan. Such elastin-hyaluronan composites may be useful to tissue engineer replacements for the glycosaminoglycan- and elastin-rich layers of the native aortic valve cusp. Neonatal rat aortic smooth muscle cells were cultured atop hylan gels with micro-textured surfaces, and on plastic, and the components of the extracellular matrix (collagen, elastin) were periodically analyzed. The hylan substrates induced the cells to proliferate more rapidly and over longer time periods (approximately 4 weeks) relative to those cultured on plastic (2-3 weeks). Consequently, at all assay times, the amounts of elastin was derived from the hylan-based cell cultures was 25% or more than that derived from cells cultured on plastic. However, when elastin content was normalized to the cell DNA content, no significant differences were found in the two substrates beyond the first two weeks of culture. Conversely, at culture times greater than 2 weeks, cells cultured atop hylan gels produced amounts of collagen/nanogram of DNA that were approximately 56% less than that synthesized by cells cultured on plastic. Cells grown on hylan deposited an unusual matrix layer, rich in elastin, at the hylan-cell interface. This elastin was found to be organized into fenestrated sheets and loose elastin fibers, structures that were also isolated from the elastin matrix of the ventricularis layer of porcine aortic valve cusps. We have thus demonstrated that hylan gels are useful as substrates to induce elastin synthesis in culture to obtain structures that resemble the elastin matrix of the native aortic valve.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tribology and Lubrication Engineering · Proteoglycans and glycosaminoglycans research · Cardiac Valve Diseases and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (31)
Show source-provided references
1. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses10.1161/01.CIR.89.2.635 ↗
2. Mechanical heart valves10.1016/S0046-8177(87)80357-X ↗
3. Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure
4. The SynerGraft valve
5. Towards tissue engineering of a composite aortic valve
6. Micromechanics of the fibrosa and the ventricularis in aortic valve leaflets10.1016/0021-9290(92)90249-Z ↗
7. The role of elastin in aortic valve mechanics10.1016/S0021-9290(97)00122-X ↗
8. Morphology of porcine aortic valve cusp elastin
9. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves
10. Acidic glycosaminoglycans in human heart valves10.1016/0022-2828(81)90316-3 ↗
11. Hylan gel biomaterial10.1002/jbm.820270903 ↗
12. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid10.1021/bc9701095 ↗
13. Crosslinking of hyaluronic acid with water-soluble carbodiimide10.1002/(SICI)1097-4636(199711)37:2<243::AID-JBM14>3.0.CO;2-F ↗
14. The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation
15. Evaluation of hylan b gel as a soft-tissue augmentation implant material10.1016/S0190-9622(97)70241-X ↗
16. Effect of hylan on cartilage and chondrocyte cultures10.1002/jor.1100100104 ↗
17. Larsen NE, Leshchiner E, Balazs EA, Belmonte C. Biocompatibility of hylan polymers in various tissue compartments. In: Mikos A.G. et al., editors. Polymers in Medicine and Pharmacy, Proceedings of the Materials Research Society. Pittsburgh, PA: Materials Research Society; 1995. p. 149–53.10.1557/PROC-394-149 ↗
18. Ultraviolet light—induced modification of crosslinked hyaluronan gels10.1002/jbm.a.10588 ↗
19. Alteration of the extracellular matrix of smooth muscle cells by ascorbate treatment10.1016/0304-4165(85)90125-4 ↗
20. Balazs EA, Leshchiner A. Crosslinked gels of hyaluronic acid and products containing such gels. US Patent No. 4,582,865, April 15, 1986.
21. The synthesis of elastin, collagen, and glycosaminoglycans by high-density primary cultures of neonatal rat aortic smooth muscle. An ultrastructural and biochemical study
22. A simple, rapid, and sensitive DNA assay procedure10.1016/0003-2697(80)90165-7 ↗
23. Stegeman H, Stalder K. Clin Chim Acta. 1967; 18: 267–73.10.1016/0009-8981(67)90167-2 ↗
24. Influence of extracellular matrix on elastin biosynthesis
25. Glycosaminoglycans mediate the coacervation of human tropoelastin through dominant charge interactions involving lysine side chains10.1074/jbc.274.31.21719 ↗
26. Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas10.1083/jcb.105.3.1463 ↗
27. Functional interplay between interleukin-I receptor and elastin binding protein regulates fibronectin production in coronary artery smooth muscle cells10.1006/excr.1996.0163 ↗
28. Versican10.1016/S0955-0674(02)00375-7 ↗
29. Hyaluronan affects protein and collagen synthesis by in vitro human skin fibroblasts10.1054/tice.2001.0180 ↗
30. Hyaluronan and rat renal fibroblasts10.1159/000046019 ↗
31. Evidence For redifferentiation of human chondrocytes grown on a hyaluronan-based biomaterial (HYAFF 11)10.1016/S0142-9612(01)00236-8 ↗